Search Results 861-870 of 18646 for Activation

  1. Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers

    Gendler, “It appears very likely that each round of treatment stimulates the bone marrow to churn out freshly activated ... activate human monocytes to seek out ...

  2. Publications - Brianna C. Leigh, M.D. - Mayo Clinic

    Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps. J ...

  3. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

    ... Activation (IA) in de Novo Kidney Transplant Recipients Scottsdale/Phoenix, AZ; Rochester, MN; Jacksonville, FL. This study will compare the incidence of a ...

  4. Publications - Ashley M. Egan, M.D. - Mayo Clinic

    Antifibrotics Modify B-Cell-induced Fibroblast Migration and Activation in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021 Jun ...

  5. Adil E. Bharucha, M.B.B.S., M.D.

    Physician/Executive OwnerTransforming the Activation of Clinical Trials (TACT) Project. 2013 - present. Executive Committee MemberClinical and Translational ...

  6. Mayo Clinic: Researchers to Study Body's Defense System to Find New Treatments for Alzheimer's

    "When activated, human innate immunity results in inflammation, and previous research on this response to development of Alzheimer's disease has been ...

  7. Return to Sport Programming for Patients with Postural Orthostatic Tachycardia Syndrome - Mayo Clinic

    Active and uncontrolled Mast Cell Activation Syndrome: As diagnosed by referring physician; Current statement by WHO states diagnostic criteria includes 2 or ...

  8. Publications - Zach Z. Thompson, M.D. - Mayo Clinic

    Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with ...

  9. Publications - David M. Nestler, M.D., M.S. - Mayo Clinic

    Enayati M, Heaton H, Wang R, Marisamy G, Farahani NZ, Hellmich T, Pasupathy K, Kim B, Nestler D. Trauma Activation Responsiveness: An RFID-enabled trauma ...

  10. A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    * Actionable epidermal growth factor receptor (EGFR) activating mutations. * Participants who have received prior c-Met-targeted antibodies, prior ...